Dr. Jasleen Kaur Pannu, MD

Dr. Pannu practices at Executive Health - HOPD in Columbus, Ohio.

Dr. Pannu's NPI, 1215226337, was assigned on March 29, 2011. Dr. Pannu holds Ohio license 35.134544.

Dr. Pannu's primary practice is Executive Health - HOPD, at 300 W 10th Ave, Columbus, OH 43210.

Dr. Pannu's primary practice is Executive Health - HOPD in Columbus, Ohio. Dr. Pannu is also affiliated with Ohio State University Hospital. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Pannu to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pannu practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Pannu's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Pannu's licenses on file in 2 states: Ohio and Minnesota.

CMS data shows 481 Medicare services from Dr. Pannu across 15 procedure codes in 2024, for 188 Medicare patients. Medicare paid $40,511 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 188 Medicare patients who saw Dr. Pannu in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pannu's median patient age at 66, with 52% women.

In 2024, Dr. Pannu wrote 17 Medicare Part D claims for 16 patients. 94% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $72 in total drug cost.

Dr. Pannu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pannu as offering telehealth.

Dmand AI links 27 papers to Dr. Pannu, published from 2010 to 2025. 2019 was the busiest year, with 5. The most frequent topics are Bronchoscopy, Lung and Pleural Effusion, Malignant. Dr. Pannu has published most often in J Bronchology Interv Pulmonol. Dr. Pannu's most frequent co-authors are Robert James Lentz, MD, Lonny Yarmus, DO and Zachary Scott Depew, MD.

Dmand AI links Dr. Pannu to 1 clinical trial. Conditions studied include Pleural Effusion and Pleural Diseases.

CMS Open Payments shows 33 general payments to Dr. Pannu from 7 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 39% of the total. AstraZeneca Pharmaceuticals LP paid the most, $4,244.